Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates lipopolysaccharide-induced cellular injury in lung alveolar epithelial cells

Human alveolar epithelial cells play a critical role in the pathogenesis of lung diseases. The objective of this study is to determine the contribution of beraprost sodium, a prostaglandin I_2 (PGI_2) analogue, to inflammatory and oxidative events in response to lipopolysaccharide (LPS) in airway epithelial cells. Materials and methods: Human pulmonary alveolar epithelial cells (A549) were pretreated with 10 µM beraprost sodium 30 min before stimulation with 1 µg/mL LPS for 24 h. The cellular viability assessments were evaluated by quantitative MTT test. Catalase activity and glutathione and lipid peroxidation levels were determined using spectrophotometric techniques. mRNA expression analyses were performed by real-time qRT-PCR. Results: The endotoxin induced a dose-dependent increase in proliferation of the cells, which was suppressed by the beraprost sodium treatment. LPS increased the expressions of TNF-\alpha and IL-1\beta genes by 8- and 2.5-fold, respectively. It also induced lipid peroxidation and depleted cellular antioxidant capacity. Pretreatments of the cells with beraprost sodium significantly reversed the inflammation and suppressed oxidative stress. Conclusion: These findings suggest that beraprost sodium will provide a pivotal molecular basis for the design of new therapeutic strategies to cure endotoxin-induced lung injury, although additional comprehensive studies are still required.

Anahtar Kelimeler:

Lung, epithelial cells, beraprost sodium, lipopolysaccharide, inflammation, oxidative stress

Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates lipopolysaccharide-induced cellular injury in lung alveolar epithelial cells

Keywords:

Lung, epithelial cells, beraprost sodium, lipopolysaccharide, inflammation, oxidative stress,

PDF

___

Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334–1349.
Droemann D, Goldmann T, Branscheid D, Clark R, Dalhoff K, Zabel P, Vollmer E. Toll-like receptor 2 is expressed by alveolar epithelial cells type II and macrophages in the human lung. Histochem Cell Biol 2003, 119: 103–118.
Puig F, Fuster G, Adda M, Blanch L, Farre R, Navajas D, Artigas A. Barrier protective effects of activated protein C in human alveolar epithelial cells. PLoS ONE 2013; 8: e56965.
Knight DA, Steward GA, Thompson PJ. The respiratory epithelium and airway smooth muscle homeostasis. Clin Exp Allergy 1994; 24: 698–706.
Song L, Zhu Y, Jin M, Zang B. Hydroxysafflor yellow a inhibits lipopolysaccharide-induced inflammatory signal transduction in human alveolar epithelial A549 cells. Fitoterapia 2013; 84: 107–114.
Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–1310.
Raetz CR, Ulevitch RJ, Wright SD, Sibley CH, Ding A, Nathan CF. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J 1991; 5: 2652–2660.
Bogatcheva NV, Zemskova MA, Kovalenkov Y, Poirier C, Verin AD. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability. J Cell Physiol 2009; 221: 750–759.
Wu TT, Chen TL, Loon WS, Tai YT, Cherng YG, Chen RM. Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-kB. Cytokine 2011; 55: 40–47.
Mosenden R, Taskén K. Cyclic AMP-mediated immune regu- lation-overview of mechanisms of action in T cells. Cell Signal 2011; 23: 1009–1016.
Wang WL, Kuo CH, Chu YT, Huang CH, Lam KP, Huang SK, Jong YJ, Kuo YT, Hung CH. Prostaglandin I(2) analogues sup- press TNF-α expression in human monocytes via mitogen- activated protein kinase pathway. Inflamm Res 2011; 60: 655– 663.
Brown DM, Hutchison L, Donaldson K, MacKenzie SJ, Dick CA, Stone V. The effect of oxidative stress on macrophages and lung epithelial cells: the role of phosphodiesterases 1 and 4. Toxicol Lett 2007; 168: 1–6.
Chen Y, Hanaoka M, Chen P, Droma Y, Voelkel NF, Kubo K. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol 2009; 296: L648–656.
Ziady AG, Sokolow A, Shank S, Corey D, Myers R, Plafker S, Kelley TJ. Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in cystic fibrosis airway epi- thelial cells. Am J Physiol Lung Cell Mol Physiol 2012; 302: L1221–1231.
Zhang A, Dong Z, Yang T. Prostaglandin D2 inhibits TGF-be- ta1-induced epithelial-to-mesenchymal transition in MDCK cells. Am J Physiol Renal Physiol 2006; 291: F1332–1342.
Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res 2003; 93: 523–530.
Ohta S, Nakamuta M, Fukushima M, Kohjima M, Kotoh K, Enjoji M, Nawata H. Beraprost sodium, a prostacyclin (PGI) analogue, ameliorates concanavalin A-induced liver injury in mice. Liver Int 2005; 25: 1061–1068.
Ueno Y, Koike H, Annoh S, Nishio S. Anti-inflammatory ef- fects of beraprost sodium, a stable analogue of PGI2, and its mechanisms. Prostaglandins 1997; 53: 279–289.
Mishima K, Baba A, Matsuo M, Itoh Y, Oishi R. Protective ef- fect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radic Biol Med 2006; 40: 1564–1577.
Kainoh M, Maruyama I, Nishio S, Nakadate T. Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem Pharmacol 1991; 41: 1135–1140.
Geiger J, Aneja MK, Hasenpusch G, Yüksekdag G, Kummerlöwe G, Luy B, Romer T, Rothbauer U, Rudolph C. Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues. Biomaterials 2010; 31: 2903–2911.
Chen Y, Luo H, Kang N, Guan C, Long Y, Cao J, Shen Q, Li J, Yang M, Peng H et al. Beraprost sodium attenuates cigarette smoke extract-induced apoptosis in vascular endothelial cells. Mol Biol Rep 2012; 39: 10447–10457.
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968; 25: 192–205.
Luck H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. Weinheim, Germany: Chemie; 1965.
Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygens toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372–376.
Sharma M, Sharma S, Roy S, Varma S, Bose M. Pulmonary epithelial cells are a source of interferon-gamma in response to Mycobacterium tuberculosis infection. Immunol Cell Biol 2007; 85: 229–237.
Larsson BM, Larsson K, Malmberg P, Palmberg L. Gram posi- tive bacteria induce IL-6 and IL-8 production in human alveo- lar macrophages and epithelial cells. Inflammation 1999; 23: 217–230.
Muroya M, Chang K, Uchida K, Bougaki M, Yamada Y. Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549. Biosci Trends 2012; 6: 70–80.
Scher JU, Pillinger MH. The anti-inflammatory effects of prostaglandins. J Investig Med 2009; 57: 703–708.
Nagao K, Tanaka H, Komai M, Masuda T, Narumiya S, Nagai H. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 2003; 29: 314–320.
Kelly MG, Alvero AB, Chen R, Silasi DA, Abrahams VM, Chan S, Visintin I, Rutherford T, Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian can- cer. Cancer Res 2006; 66: 3859–3868.
Hattar K, Savai R, Subtil FS, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B, Dahlem G, Fink L et al. Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation. Cancer Immunol Immunother 2013; 62: 309–320.
di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, Escala N, Vandenbroeck K, Comella JX, Villoslada P. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS ONE 2013; 8: e54722.
Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A. Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pul- monary artery. Am J Respir Cell Mol Biol 2002; 26: 194–201.
Erdogan S, Aslantas O, Celik S, Atik E. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection. Res Vet Sci 2008; 84: 18–25.
Lucchi S, Calebiro D, de Filippis T, Grassi ES, Borghi MO, Per- sani L. 8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through differ- ent mechanisms. PLoS ONE 2011; 6: e20785.
Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. Molecular mechanisms of the antiproliferative effect of beraprost, a pros- tacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 2008; 214: 434–441.
Sue YM, Chung CP, Lin H, Chou Y, Jen CY, Li HF, Chang CC, Juan SH. PPARd-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost- induced antiproliferation of murine aortic. Am J Physiol Cell Physiol 2009; 297: 321–329.
Boots AW, Gerloff K, Bartholomé R, van Berlo D, Ledermann K, Haenen GR, Bast A, van Schooten FJ, Albrecht C, Schins RP. Neutrophils augment LPS-mediated pro-inflammatory signal- ing in human lung epithelial cells. Biochim Biophys Acta 2012; 1823: 1151–1162.
Aggarwal S, Dimitropoulou C, Lu Q, Black SM, Sharma S. Glutathione supplementation attenuates lipopolysaccharide- induced mitochondrial dysfunction and apoptosis in a mouse model of acute lung injury. Front Physiol 2012; 3: 161.
Choi JS, Lee HS, Seo KH, Na JO, Kim YH, Uh ST, Park CS, Oh MH, Lee SH, Kim YT. The effect of post-treatment N- acetylcysteine in LPS-induced acute lung injury of rats. Tuberc Respir Dis (Seoul) 2012; 73: 22–31.
Nader MA, Baraka HN. Effect of betulinic acid on neutro- phil recruitment and inflammatory mediator expression in lipopolysaccharide-induced lung inflammation in rats. Eur J Pharm Sci 2012; 46: 106–113.
Goodman, RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediat- ed inflammation in acute lung injury. Cytokine Growth Factor Rev 2003; 14: 523–535.
Zhou W, Hashimoto K, Goleniewska K, O’Neal JF, Ji S, Black- well TS, Fitzgerald GA, Egan KM, Geraci MW, Peebles RS Jr. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol 2007; 178: 702–710.
Feng T, Yunfeng N, Jinbo Z, Zhipei Z, Huizhong Z, Li L, Tao J, Yunjie W. Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Chem Biol Interact 2010; 183: 442–449.